10.1085/jgp.201812263 292
For oral L-carnitine, be sure to take it with meals to maximize its effectiveness
AstraZeneca / Daiichi Sankyo Enhertu Redefines First-Line HER2+ Metastatic Breast Cancer Care Enhertu (trastuzumab deruxtecan), an antibodydrug conjugate, became the first ADC approved for first-line treatment of HER2-positive metastatic breast cancer after delivering a marked improvement in progression-free survival versus the long-standing THP standard in the Phase III DESTINY-Breast09 trial
Clinical Evidence Supporting Combined Therapy Diagram from the NADPARK study detailing the design and outcomes of a phase I trial on nicotinamide riboside supplementation in Parkinsons disease
Calming Calendula Spray apply post-treatment for additional soothing support on rosacea-prone or recently-treated skin
The underlying mechanisms are multifactorial and not fully understood, but increasing evidence highlights the gutbrain axis and the intestinal microbiome as critical contributors to disease onset and progression (He et al., 2023